OMERS Growth Equity

OMERS Growth Equity operates as a significant investment arm of OMERS, focusing on direct equity investments in high-growth technology and healthcare companies globally. It provides capital to businesses poised for substantial expansion, employing a long-term investment horizon to support their development and market leadership. The division primarily targets established companies seeking capital to scale operations, innovate products, or expand geographically, often becoming a strategic partner.

OMERS Growth Equity was formally established in 2019 as an extension of OMERS, one of Canada's largest defined benefit pension plans, which itself was founded in 1962. The creation of this dedicated growth equity unit arose from OMERS' strategic insight to diversify its investment portfolio and capture value from rapidly expanding private companies. This move allowed OMERS to directly engage with and foster innovation within the burgeoning technology and life sciences sectors, leveraging its extensive capital base.

The primary entities benefiting from OMERS Growth Equity are the portfolio companies themselves, which gain access to substantial capital and strategic guidance to accelerate their development. OMERS Growth Equity aims to generate robust, long-term returns to help fulfill the pension obligations of OMERS' over half a million members. Its vision is to be a leading global investor in the growth equity space, identifying and backing promising companies that demonstrate potential for sustainable value creation and sector disruption.